Clinical activity of irofulven in hormone refractory prostate cancer.

被引：0
|
作者：
Cvitkovic, E
Kahatt, C
Senzer, N
Tombal, B
Culine, S
Raymond, E
Alexandre, J
Weems, G
MacDonald, J
机构：
[1] Cvitkovic & Associes Consultants, Le Kremlin Bicetre, France
[2] Mary Crowley Med Res Ctr, US Oncol, Dallas, TX USA
[3] UCLC St Luc, Brussels, Belgium
[4] CRLC, Montpellier, France
[5] Inst Gustave Roussy, Villejuif, France
[6] Hop Cochin, F-75674 Paris, France
[7] MGI Pharma Inc, Bloomington, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4766
引用
收藏
页码：447S / 447S
页数：1
相关论文
共 50 条
  • [41] Prognostic and predictive clinical factors for progression to castration refractory prostate cancer in patients with hormone sensitive prostate cancer
    Watanabe, M.
    Kanao, K.
    Sugie, M.
    Morinaga, S.
    Muramatsu, H.
    Kobayashi, I.
    Kajikawa, K.
    Nishikawa, G.
    Zennami, K.
    Nakamura, K.
    Sumitomo, M.
    ANNALS OF ONCOLOGY, 2018, 29 : 73 - 73
  • [42] A combination of irofulven and oxaliplatin is active in patients with hormone refractory prostate cancer (HRPC) with secondary resistance to docetaxel: Phase I preliminary evidence.
    Tchen, N
    Alexandre, J
    Misset, JL
    Berthault-Cvitkovic, F
    Kahatt, C
    Benettaib, B
    Weems, G
    MacDonald, JR
    Cvitkovic, E
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9057S - 9058S
  • [43] Systemic treatment of hormone refractory prostate cancer
    H. Rübben
    A. Bex
    T. Otto
    World Journal of Urology, 2001, 19 : 99 - 110
  • [44] Management of the spectrum of hormone refractory prostate cancer
    Clarke, Noel W.
    EUROPEAN UROLOGY, 2006, 50 (03) : 428 - 439
  • [45] Response of hormone refractory prostate cancer to lycopene
    Matlaga, BR
    Hall, MC
    Stindt, D
    Torti, FM
    JOURNAL OF UROLOGY, 2001, 166 (02): : 613 - 613
  • [46] Taxanes in hormone-refractory prostate cancer
    Kang, MH
    Figg, WD
    Dahut, W
    CANCER PRACTICE, 1999, 7 (05) : 270 - 272
  • [47] Chemotherapy for advanced hormone refractory prostate cancer
    Petrylak, DP
    UROLOGY, 1999, 54 (6A) : 30 - 35
  • [48] New approaches in hormone refractory prostate cancer
    Sonpavde, G
    Hutson, TE
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (02): : 196 - 201
  • [49] Chemotherapy in hormone-refractory prostate cancer
    de Wit, Ronald
    BJU INTERNATIONAL, 2008, 101 : 11 - 15
  • [50] Therapy of hormone-refractory prostate cancer
    不详
    ANTICANCER RESEARCH, 2005, 25 (6D) : 4796 - 4796
12345